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Abstract
Since the pathogenesis of atopic dermatitis could not be explained only by a 
population genetic and phenotypic profiles, epigenetic regulator factors have been 
considered. Epigenetics is the study of inherited changes in gene expression that 
are not related to changes in its nucleotide sequence. One of the main classical 
regulatory mechanisms in human cells is DNA methylation. It is not clear how 
permanent modifications caused by this process are and whether it is possible to 
affect them by changing the activity of enzymes that trigger remodeling reactions. 
In this chapter we analyze all recent studies in this field. We focus more on meth-
ylation of innate and adaptive immune factors, with an emphasis on T-lymphocyte 
genes such as CD3, CD4, and CD8.
Keywords: atopic dermatitis, epigenetics, DNA methylation, genome-wide 
methylation analysis, immune system
1. Introduction
Atopic dermatitis (AD) is a chronic recurrent inflammation of the skin, 
characterized by impairment of the epidermal barrier that entailing its further 
dysfunction. The predisposition to IgE-mediated hypertension contributes to such 
a malfunction, realized in sensitization to surrounding allergens [1]. This pathology 
is also characterized by infiltration and accumulation of type 2 T helper cells (Th2) 
and eosinophils [2]. Atopic dermatitis is a multifactorial disease. The main triggers 
are various genetically predetermined defects of the epidermal barrier and the 
immune system influenced by environment [1].
Thus, the study of tissues and cells transcriptome involved in the pathogenesis 
of the disease is one of the best options for detecting molecular signs of complex 
diseases such as AD [3]. In one of these studies, it was found that the expression of a 
large number of genes which were responsible for terminal differentiation of kera-
tinocytes was reduced in case of AD compared with healthy controls. These genes 
include filaggrin (FLG), loricrin (LOR), involucrin, late cornified envelope protein 
LCE2B, and genes encoding the S100 family of proteins [4]. This study showed 
that AD is associated with impaired keratinization processes in the epidermis, and 
confirmed another profile study by Sugiura et al., where suppression of LOR and 
FLG expression was determined in the lesional skin [5]. With the help of RNA 
sequencing technology by which transcriptomes of intact and damaged skin of 
patients with moderate and severe AD were compared, an increased expression of 
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the TREM-1 signaling pathway, as well as IL-36, was revealed [6]. The laser capture 
microdissection method once again confirmed that the expression of genes encoding 
skin barrier proteins, including FLG, LOR, CLDN4 and CLDN8, is reduced in affected 
atopic skin; and, on the contrary, the expression of cytokines Th2 and Th17 genes, 
such as CCL22, CCL26, TSLP, and IL-22 etc., is increased [7].
Loss of function mutations in the gene encoding FLG are one of the most signifi-
cant genetic risk factors for AD. A transcriptome profiling study realized by RNA 
sequencing revealed differentially expressed genes involved in the extracellular 
reactions, lipid metabolism, and stress response. In FLG-deficient skin, the stress 
response mediated by type I interferon (IFN) was expressed [8].
However, genetic changes solely do not fully shed light on the molecular 
mechanisms involved in the pathogenesis of AD. Therefore, epigenetic mecha-
nisms involved in the genomic adaptation according to environmental conditions 
may possibly explain how environmental exposure affects the risk of allergy 
development.
Epigenetic mechanisms, in particular methylation, play a key role in immune 
regulation and are influenced by a variety of environmental factors leading to 
persistent molecular changes in genes. The methylation process involves the addi-
tion of a methyl group to the cytosine (C5 position; 5-methylcytosine, 5mC). DNA 
methylation occurs primarily in the context of CpG dinucleotides and is the main 
epigenetic modification involved in the regulation of chromatin structure and gene 
expression [9].
2. Targeted methylation studies
2.1 DNA methyltransferase studies
The main enzymes responsible for the methylation process in humans are DNA 
methyltransferases 1, 3a, and 3b (DNMT1, DNMT3a, and DNMT3b). It is generally 
accepted that DNMT3a and DNMT3b are de novo methyltransferases that form a 
model of DNA methylation at early stages of development, as well as its changes 
during cell differentiation [10]. DNA methyltransferase 1 (DNMT1) maintains the 
methylated state of DNA by attaching methyl groups to one of the DNA strands at 
the sites where the other complementary strand is methylated [9].
In the context of the AD study, only DNA methyltransferase-1 (DNMT-1), an 
enzyme that catalyzes the methylation of cytosine bases in CpG islands, has so far 
been considered. Nakamura et al. for the first time carried out an indirect assess-
ment of methylation status in patients with atopic dermatitis by measuring the 
expression of messenger RNA (mRNA) of DNA methyltransferase-1 in peripheral 
blood mononuclear cells (PBMC) by quantitative RT-PCR. Although the expression 
level of DNMT-1 mRNA had a tendency to decrease in patients with atopic derma-
titis compared with healthy controls, there were no significant differences between 
these groups [11]. However, in the group of patients with AD, the IgE level was also 
taken into account. It was found that the level of DNMT-1 mRNA was significantly 
lower in the high IgE group compared to the control group.
It is common knowledge that many local factors, such as skin impairment, play 
an important role in the development of AD [12, 13]. However, Th2-infiltration in 
response to penetration of allergens and production of cytokines by infiltrated cells 
(for example, IL-4 and IL-5) plays the key role in the development of IgE-mediated 
response and chronic inflammation involving eosinophils [14–16]. It is assumed 
that in these processes DNA hypomethylation contributes to the hyperreactivity 
of Th2 cells in response to allergens and, as a consequence, cytokine-mediated 
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IgE production. It has also been suggested that IL-4-mediated IgE production in 
patients with high serum IgE levels is associated with DNA hypomethylation in B 
cells [16, 17]. In this study the decrease in DNMT-1 expression in PBMCs in patients 
with high IgE levels also confirmed the concept that AD is promoted by lower 
DNMT-1 levels.
On the other hand, the lack of significant differences while comparing DNMT-1 
expression between groups with high and low IgE levels, along with no correla-
tion between DNMT-1 expression and serum IgE levels in the respective patients, 
indicates that DNMT-1 cannot be a factor that solely affects serum IgE. To clarify 
this issue, more studies are needed in which DMNT-1 levels would be assessed in 
patients without AD but with high serum IgE levels.
2.2 FCER1G methylation studies
Based on the opinion that overexpression of the high-affinity IgE receptor on 
monocytes and dendritic cells contributes to the pathogenesis of AD, a group of 
scientists studied the epigenetic mechanism of deregulation of high-affinity IgE 
receptors – FcεRI [18].
Liang et al. measured the methylation level of total DNA of monocytes from 
10 patients with AD and 10 healthy people from the control group. Bisulfite 
sequencing was used as the main method to determine the methylation status of 
the FCER1G promoter region. To determine the functional significance of meth-
ylation changes in FcεRI expression, targeted methylation of the sequence and a 
demethylating agent, 5-azacytidine (5-aza), were used. The levels of FcεRIγ mRNA 
and FcεRI protein were determined using RT-PCR RT, Western blotting, and flow 
cytometry, respectively.
Thus, total hypomethylation in CD14+ monocytes in patients with AD was 
revealed, as well as locus-specific hypomethylation of the FCER1G promoter region 
in comparison with healthy controls. In addition, hypomethylation of FCER1G 
contributed to its increased expression. Targeted methylation in combination with 
a reporter luciferase assay confirmed this association between methylation and 
expression. Moreover, treatment of monocytes of healthy people with 5-azacytidine 
caused a decrease in methylation levels and induction of FcεRIγ transcription and 
expression of surface FcεRI. The authors showed that demethylation of specific 
regulatory elements at the FCER1G locus promotes an increase in FcεRI expression 
in monocytes in patients with AD, which, in turn, leads to an enhanced allergic 
response.
Atopic monocytes with high FcεRI levels are thought to play an important role 
in the pathogenesis of AD. This is due to the fact that monocytes carrying FcεRI can 
differentiate into inflammatory dendritic epidermal cells (IDECs), which intensify 
allergic inflammatory reactions in the skin by stimulating T cells, and are also 
involved in the transition to the chronic course of AD with a predominance of Th2 
[19, 20]. In this study, it was shown for the first time that changes in the epigenetic 
regulation of the FCER1G gene can explain the pathological activation of FcεRI on 
patient monocytes.
2.3 TSLP methylation studies
Thymic stromal lymphopoietin (TSLP) plays an important role in maintaining 
T-cell homeostasis and, apparently, is of great importance in the development of 
allergic symptoms, especially in atopic dermatitis and asthma [21, 22]. Human TSLP 
is overexpressed in keratinocytes of patients with acute and chronic AD. However, 
the mechanism of such TSLP expression remains unclear. The question is whether 
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TSLP expression is regulated by modification of aberrant DNA methylation of 
TSLP promoter in keratinocytes of AD patients [23].
It is known that the TSLP protein cannot be found in healthy skin, in skin lesions 
in patients with nickel contact dermatitis or in patients with disseminated lupus 
erythematosus, as well as in intact skin in patients with AD; however, increased 
levels of TSLP expression are observed in both acute and chronic atopic skin lesions 
[21, 24]. TSLP overexpression in keratinocytes can activate myeloid dendritic 
cells by enhancing the surface expression of CD54, CD80, CD83, CD86 molecules 
and MHC class II molecules on myeloid dendritic cells [25], which lead to Th2-
inflammatory reactions [24].
Luo et al. measured the levels of mRNA and TSLP protein in samples of affected 
skin from 10 atopic children and 10 healthy people from the control group, using 
quantitative RT-PCR and immunohistochemistry [26]. Bisulfite sequencing was 
performed to determine the methylation status of the TSLP promoter; 5-aza, a DNA 
methyltransferase inhibitor, was used to determine the effect of DNA methylation 
on TSLP expression.
As a result, the levels of expression of mRNA and TSLP protein relative to 
β-actin were significantly higher in affected skin regions of patients with AD com-
pared with healthy controls. In addition, hypomethylation of the promoter region 
of the TSLP gene containing 16 CG pairs was found in the affected skin regions. 
Upon treatment of HaCaT cell line keratinocytes with 5-aza, the methylation level 
of the TSLP promoter decreased significantly, while its transcription increased.
It can be concluded that DNA demethylation of the specific regulatory region 
of the TSLP gene may contribute to the overexpression of TSLP in the affected skin 
regions in atopic patients. This suggests that aberrant epigenetic modifications play 
an important role in the pathogenesis of this disease.
In another study, the authors tried to reveal the effect of prenatal smoking on 
DNA methylation in case of atopic disorders [27]. Methylation differences associ-
ated with exposure to tobacco smoke were initially identified with the use of 
Illumina Infinium 27 K methylation kits in 14 children in a Taiwanese study cohort. 
Information on the course of the disease and possible risk factors was collected. Cord 
blood levels of cotinine were measured in order to represent prenatal smoking. CpG 
loci, in which statistically significant differences in methylation were found, were 
validated by methylation-dependent fragment separation (MDFS). Differential 
methylation in three genes (TSLP, GSTT1, and CYB5R3) was detected during the 
experiment. Among these, only the TSLP gene showed a significant difference in 
the percentage of promoter methylation after testing with MDFS. The TSLP gene 
was further investigated in a larger sample group (150 children) which completed 
a follow-up study. The TSLP 5’-CpG island (5’CGI) methylation status has been 
found to be significantly associated with prenatal exposure to smoke and atopic 
dermatitis. The degree of the TSLP 5’CGI methylation was inversely correlated with 
the expression levels of the TSLP protein.
Thus, it can be assumed that changes in TSLP 5’CGI methylation decrease the 
regulatory function of the immune system and cause the development of Th2-type 
allergic inflammation in case of atopic dermatitis. The methylation status of TSLP 
5’CGI was also found to differ depending on cotinine levels, and hypomethylated 
TSLP 5’CGI was positively associated with atopic dermatitis. Moreover, the degree 
of TSLP 5’CGI methylation and the level of TSLP protein showed an inverse correla-
tion. This means that severe exposure to smoke can lead to TSLP 5’CGI hypometh-
ylation. Therefore, hypomethylated TSLP 5’CGI is associated with increased gene 
expression and increased TSLP protein concentration. An increased level of TSLP 
protein may also activate Langerhans epidermal cells, contributing to the AD devel-
opment. TSLP was also highly expressed in the lesional skin of atopic patients [24].
5
Epigenetic Studies of Atopic Dermatitis
DOI: http://dx.doi.org/10.5772/intechopen.94092
The results of Wang et al. study suggest that prenatal exposure to tobacco smoke 
is associated with a risk of atopic dermatitis, possibly through DNA methylation.
2.4 MICAL3 methylation studies
Cho et al. conducted a research to assess the role of 25-hydroxyvitamin D 
(25[OH]D) deficiency in cord blood in comparison with postnatal 25[OH]D levels 
in AD development during the first 3 years of life and found out how 25[OH]D 
deficiency affects the DNA methylation profile of cord blood leukocytes [28].
Severe 25[OH]D deficiency in cord blood was associated with a higher risk of 
atopic dermatitis diagnosing precisely at the age from 2 to 3. Comparison of differ-
entially methylated CpG sites in accordance with moderate and insufficient 25[OH]
D levels in cord blood revealed the common MICAL3 gene for groups with and 
without pathology. MICAL3 was hypomethylated in the case of low 25[OH]D levels.
Since MICAL3 is a member of the MICAL family of flavoprotein monooxy-
genases involved in axon control and actin remodeling through oxidation of its 
molecules or production of reactive oxygen species (ROS) [29], ROS, induced by 
increased expression of MICAL3, can then suppress the antioxidant defense of the 
fetus, leading to subsequent AD development during the first 3 years of life. This 
process probably also affects the severity of the disease, since a correlation has 
been established between the expression of MICAL3 mRNA and the severity index 
of atopic dermatitis. In addition, MICAL3 expression levels were associated with 
25[OH]D levels in cord blood regardless of the presence of AD.
To reproduce the mechanism of atopic dermatitis associated with ROS, using 
the example of MICAL3, another gene was chosen, 8-oxoguanine-DNA glycosylase 
(OGG1), which, as is known from data on mRNA expression, contributes to the 
development of allergic diseases in combination with oxidative stress reactions 
[30]. Accordingly, in atopic children with 25[OH]D deficiency in cord blood, the 
expression of OGG1 mRNA was 5.22 times higher than in healthy children with 
a sufficient level of 25[OH]D. OGG1 expression levels were found to be inversely 
related to 25[OH]D levels and atopic dermatitis severity index. In addition, there 
is a significant correlation between the expression levels of MICAL3 and OGG1. 
However, studies showing that MICAL3 and OGG1 are directly related have not yet 
been conducted.
2.5 HBD-1 methylation studies
Noh et al. described patterns of DNA methylation of human β-defensin-1 
(HBD-1), a unique antimicrobial peptide expressed in various tissues, including 
the skin [31]. HBD-1 may be associated with a variety of innate immune system 
defects in the AD pathogenesis. A possible mechanism for the decrease in HBD-1 
gene expression in atopic dermatitis was investigated, and the HBD-1 transcription 
restoration in undifferentiated normal epidermal keratinocytes after treatment 
with a DNA methyltransferase inhibitor was shown.
Suppression of HBD-1 in undifferentiated NHEK cells has been shown to be 
regulated by an epigenetic inactivation mechanism involving methylation of DNA 
14 CpG dinucleotide in the 5′-region of HBD-1. In dermatitis-affected skin, the 
frequency of methylation at the CpG 3 and CpG 4 sites within the HBD-1 promoter 
was significantly higher than in healthy skin.
To identify specific CpG sites that play a significant role in HBD-1 expression in 
NHEK cells, bisulfite genomic sequencing of the region upstream of the proximal 
site of the HBD-1 promoter was performed and methylation profiles of 6 CpG 
dinucleotides (from CpG 3 to CpG 8) were determined. Since the single nucleotide 
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polymorphism (rs2978863) is located at the CpG 8 locus within the HBD-1 promoter 
region (GenBank accession no. NC_000008.11) in the NHEK cell line, the other 
five CpG dinucleotides (CpG 3–7) were subjected to bisulfite sequencing analysis. 
Studying the methylation profile of the HBD-1 promoter revealed detectable 
demethylation at the CpG 3 and CpG 4 loci in 2-deoxy-5-azacytidine-treated NHEK 
cells compared with untreated control cells. Such differentially methylated single 
CpG units in the HBD-1 promoter may play a special role in the regulation of HBD-1 
transcription of the NHEK cell line.
Thus, epigenetic modulation of the HBD-1 promoter, that is, DNA methylation 
in two separate CpG units, can affect HBD-1 expression in vitro. In the affected 
skin, both CpG sites were hypermethylated. The failure of skin innate immunity 
leading to increased colonization of S. aureus in atopic patients may be due to an 
epigenetic predisposition of constitutively expressed HBD-1.
3. Genome-wide DNA methylation
3.1 In naive CD4+
Both atopic dermatitis and psoriasis are characterized by a targeted immune 
response via polarized CD4+ T cells. During the polarization of naive CD4+ T cells, 
DNA methylation plays an important role in the regulation of gene transcription. 
Taken into consideration the similarity of immune response of atopic dermatitis 
and psoriasis, Han et al. conducted a study of the global DNA methylation profile 
in naive CD4+ T cells in patients with AD and psoriasis, as well as in healthy people 
using the ChIP-seq method. DNA hypomethylation (more than 4 times) was found 
in T-cell samples isolated from patients with psoriasis and healthy people in 26 
genome sites ranging in size from 10 to 70 kb. These regions were mostly pericen-
tromeric on 10 different chromosomes and randomly overlaid with various defining 
epigenome signals, such as histone modifications and binding sites for transcription 
factors (according to the ENCODE project), which implied the potential influence 
of epigenetic regulation in the development of psoriasis [32].
To determine whether naive CD4+ T cells from patients with AD or psoriasis 
have DNA methylation patterns different from those of healthy people, complex 
genome-wide CpG methylation profiling was performed. The uniquely mapped 
regions coincided with strong histone modification signals such as H3K4Me1, 
H3K27Ac, and H3K4Me3, as well as with transcription factor binding sites in various 
cell lines.
It appears that hypomethylation in some pericentromeric regions of naive CD4+ 
T cells may be a sign of psoriasis, but not atopic dermatitis. It is not yet clear what 
exact role epigenetic changes of these regions play in the development of T cells. 
However, these data show for the first time the importance of such changes in the 
development of immune-mediated skin diseases [33].
The X chromosome encodes many of immune genes, which show a higher 
hypermethylation pattern than other genes. It is known that abnormalities, such 
as inactivation of the X chromosome, can contribute to the impairment of self-
structures recognition and, ultimately, lead to autoimmunity [34]. In addition, 
DNA methylation is involved in the initiation of the X chromosome inactivation, 
as well as in the stable maintenance of the gene silencing state [35]. These studies 
suggest that DNA methylation may affect gene expression on the X chromosome 
or the development of T cells in psoriasis. It was found that DNA methylation is 
dramatically increased in the promoter region of genes on the X chromosome in 
patients with psoriasis. The binding sites for CDPCR3, GATA3, BRN2, and other 
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transcription factors were identified as slightly enriched. The data obtained on 
epigenome changes in T cells show that naive CD4+ T cells may be involved in the 
development of atopic dermatitis or psoriasis even before antigenic stimulation. 
This may be due to the effects of various environmental factors.
3.2 Tissue-specific patterns
To determine the tissue-specific differences in DNA methylation associated with 
AD, the research group of Rodriguez et al. examined the DNA of whole blood, T 
cells, B cells, as well as the affected and unaffected epidermis of atopic patients and 
healthy people from the control group [36]. To identify functional associations, 
they studied the expression profiles of epidermal mRNA.
Whole-genome methylation analysis was performed using Human Methylation27 
BeadCheap. The results for epidermal tissue were different from those for blood 
cells. To determine the intraindividual and interindividual differences in DNA 
methylation, the researchers identified a pairwise correlation of methylated regions 
in the same tissue in samples from patients of similar sex and age, as well as between 
different tissues in the same person. In whole blood, T cells, and B cells, there were 
no significant differences in genome DNA methylation in the pathology group as 
compared with and the control group, and in general, intraindividual differences 
in DNA methylation were greater than those between individuals. A clear link was 
shown in case of comparing similar tissue in different individuals for different 
CpG sites, which partially correlated with altered levels of gene transcripts, mainly 
related to the processes of epidermal differentiation (S100A genes) and reactions of 
the innate immune response - thus, this study confirms the high the level of tissue 
specificity for DNA methylation patterns.
Regarding differentially methylated CpG islands in the epidermal tissue, 9 
regions were identified as reliably associated with atopic dermatitis: in the CFLAR, 
GPR55, MMP7, LOC283487, SH2D2A, and ERP27 genes, these regions were hypo-
methylated, and in the LRRC8C, S100A5, and EBP49 genes, these regions were 
hypermethylated.
Based on analysis of whole genome mRNA expression (using HumanHT-12v3 
Expression BeadChip), significant differences were revealed in seven transcripts 
when comparing samples of the affected skin of patients with AD and the skin of 
healthy people.
From nine selected pairs of differentially methylated regions / differentially 
expressed transcripts using the EpiTYPER system and quantitative PCR, the 
following combinations associated with the development of AD were success-
fully validated: KRT6A/KRT6A and KRT6A/KRT6B (encode keratin); IFI27/IFI27, 
OAS2/OAS2 (belong to the family of proteins regulated by IFN), GDPD3/GDPD3 
and S100A5/S100A2. In most of these pairs, an inverse correlation was observed, 
that is, higher levels of methylation were associated with lower expression of the 
relevant gene, and vice versa. Such dependence is usually observed in CpG islands 
near the sites of transcription initiation, where DNA methylation is associated with 
prolonged silencing of the relevant gene.
Olisova et al. carried out a genome-wide study of DNA methylation using 
the Illumina Infinium Human Methylation450 BeadChip technology [37]. When 
comparing the affected and unaffected skin areas in atopic patients, no difference 
in the methylation profile was found. This suggests that epigenetic changes affected 
the entire skin as a whole, although they have not yet appeared in clinically intact 
skin areas. However, when comparing the affected skin with the skin of healthy 
volunteers, differentially methylated genes of the TSS200 and TSS1500 regions 
were isolated, whose protein products were involved in the pathogenesis of atopic 
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dermatitis and related processes: steroid hormone biosynthesis and cell metabo-
lism (HSD17B14, HSD17B), epithelial differentiation (KRT31, LCE3D), regula-
tion of DNA-dependent transcription and RNA processing (DMBX1, MTO1, 
SNORD93, WDR36), immune response and activation of lymphocytes (AIM2, 
CD300E, CLEC1A, DEFB135, IL23A), activation of transforming growth factor β1 
(LTBP1), cellular proliferation and apoptosis (SERPINB3, EPR1).
3.3 Replicated methylation
Another genome-wide epigenetic study examined differences in DNA methyla-
tion in atopic dermatitis together with herpetic eczema (HE), and revealed how 
methylation changes in patients with atopic dermatitis, complicated or uncompli-
cated HE [38].
490 significantly differentially methylated CpG sites were identified. Many of 
these were associated with indicators of disease severity, especially with the level of 
eosinophils (431/490 sites). One CpG region was replicated and was significantly 
differentially methylated based severity and phenotype.
The authors found replication for one CpG region associated with total serum 
IgE in the IL4 gene, as well as possible replication for four CpG regions associated 
with HE in the IL13 and IL4 genes. It has also been shown that eosinophil levels play 
an important role in methylation patterns in people with AD, which via molecular 
mechanisms can lead to phenotypic changes.
4.  Epigenetic regulation of immune system factors
It is known that abnormal epigenetic regulation of immune factors and skin 
barriers contribute to the pathogenesis of AD. During the development of immune 
system cells, epigenetic mechanisms are involved in specific changes in the variants 
of immune response [39]. Here are some examples.
Regulatory T cells (Tregs) play an important role in early immune programming 
and the formation of an adequate immune response in relation to pro-allergic or 
tolerant conditions. Tregs are best characterized by the expression of transcription 
factor 3 (Foxp3), which is important for the induction and stability of Tregs [40]. 
Foxp3 is controlled by DNA methylation of its transcriptional regulatory regions. 
Naturally induced by TGF-β Foxp3+ Tregs indicate stable expression of Foxp3, 
which is associated with selective demethylation of an evolutionarily conserved 
element at the Foxp3 locus - a Treg-specific demethylated region. Inhibition of 
DNA methylation by azacytidine, even in the absence of exogenous TGF-β, not only 
promotes induction of Foxp3 expression de novo during priming, but also ensures 
stability of Foxp3 expression upon restimulation. Importantly, stable Foxp3 expres-
sion was detected only in cells with an increased level of TSDR demethylation [41]. 
Research suggests that prenatal environmental factors can alter DNA methylation at 
the FOXP3 locus in cord blood. Babies with low Tregs identified by TSDR demeth-
ylation at birth may have a higher risk of AD developing or sensitization to food 
allergens in the first 3 years of life [42].
In the neonatal immune system, epigenetic regulation can be shifted away from 
Th1-mediated immunity in order to prevent dangerous cellular immune responses 
to the developing fetus. The IFN-γ gene (IFNG), a prototype Th1 cytokine gene 
whose activity is regulated during fetal development, is hypermethylated in the 
promoter regions of resting neonatal CD4+ cells compared to adult ones [43]. 
Similarly, the availability of chromatin at the TBX21 locus, a major regulator of Th1 
clone committing, is attenuated in neonatal CD4+ cells compared to mature cells, 
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and a decrease of transcription factor level in peripheral T cells suppresses IFN-γ 
production [44]. After birth, exposure to a variety of microorganisms and the 
formation of microbiota contributes to the essential activation of Th1 immune 
responses through epigenetic modifications. In a mouse model it was shown that 
prenatal administration of gram-negative bacteria leads to histone H4 acetyla-
tion at the IFNG gene and the associated increase in IFN-γ production in the 
offspring [45].
MicroRNAs (miRNAs) are short, single-stranded RNA molecules that func-
tion with their associated proteins and cause the degradation of targeted mRNAs, 
inhibiting their translation. miRNAs play an important role in a wide range of 
biological processes, including proliferation, differentiation, determination of cell 
development, apoptosis, signal transduction, and organ development. Some miRNAs 
are expressed specifically for each type of cells and tissues and contribute to the 
maintenance of cell identity. Tissue-specific miRNAs function at various levels of 
gene regulation, ranging from control of targeted effector genes, incompatible with 
the differentiated state, to control over the levels of transcriptional regulators and 
alternative pre-mRNA splicing. This multilevel regulation of miRNAs influences the 
gene expression program of differentiated cells [46]. miRNAs, including miR-21,  
miR-146, and miR-223, activated in patients with allergic disorders, are also 
activated in the skin of patients with AD [47]. A study by Herberth et al. showed 
that maternal exposure to tobacco during pregnancy correlated with high levels of 
miRNA-223 and low Treg cell levels, which predisposed children to atopic dermatitis 
during the first 3 years of life [48]. Sonkoly et al. found that miR-155 was one of the 
most activated miRNAs in lesional skin samples from atopic patients in comparison 
with skin samples from healthy people. It has been found that local exposure of 
relevant allergens to intact skin of patients with AD induces miR-155 expression. 
miR-155 suppresses cytotoxic T lymphocyte – associated protein 4 - CTLA-4, 
which negatively regulates the function of T cells. This suppression of CTLA-4, in 
turn, enhances the T cell proliferative response, which can then lead to a long-term 
chronic inflammatory state [47].
5. Conclusion
There is not much evidence on the role of epigenetic mechanisms of innate 
and adaptive immunity regulation in the pathogenesis of atopic diseases, as these 
mechanisms have been studied recently. The described candidate genes involved 
in pathological processes such as dysfunction of the epidermal barrier, enhanced 
transmission of Th2 immunity signals, weakened innate immune responses, etc. 
play an important role in the pathogenesis of AD. Epigenetic studies also indicate 
modifications in genes involved in these mechanisms. Dysfunction of the epithelial 
barrier and immune response reactions together trigger the development of atopic 
dermatitis.
New insights on epigenetic and immunological markers associated with the risk 
of development of atopic dermatitis will help to create new prognostic approaches 
in the management of patients with atopic pathology. In this regard, it is important 
to have a complete understanding of the pathogenic mechanisms of an allergic 
disease.
Conflict of interest
The authors declare no conflict of interest.
Atopic Dermatitis - Essential Issues
10
Author details
Vladimir Sobolev1,2*, Elizaveta Bystritskaya1 and Oxana Svitich1,3
1 I. Mechnikov Research Institute for Vaccines and Sera, Moscow, 
Russian Federation
2 Center for Theoretical Problems of Physico-Chemical Pharmacology, 
RAS Moscow, Russian Federation
3 Sechenov University, Moscow, Russian Federation
*Address all correspondence to: vlsobolew@gmail.com
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
11
Epigenetic Studies of Atopic Dermatitis
DOI: http://dx.doi.org/10.5772/intechopen.94092
References
[1] Martin MJ, Estravís M, 
García-Sánchez A, et al. Genetics and 
Epigenetics of Atopic Dermatitis: An 
Updated Systematic Review. Genes  
2020 ; 11: 442.
[2] Sacchetti B, Funari A, Michienzi S, 
et al. Self-Renewing Osteoprogenitors in 
Bone Marrow Sinusoids Can Organize a 
Hematopoietic Microenvironment. Cell 
2007; 131: 324-336.
[3] Bin L, Leung DYM. Genetic and 
epigenetic studies of atopic dermatitis. 
Allergy Asthma Clin Immunol 2016;  
12: 52.
[4] Guttman-Yassky E, Suárez- 
Fariñas M, Chiricozzi A, et al. Broad 
defects in epidermal cornification in 
atopic dermatitis identified through 
genomic analysis. Journal of Allergy and 
Clinical Immunology 2009; 124: 1235-
1244.e58.
[5] Sugiura H, Ebise H, Tazawa T, et al. 
Large-scale DNA microarray analysis of 
atopic skin lesions shows overexpression 
of an epidermal differentiation gene 
cluster in the alternative pathway and 
lack of protective gene expression in the 
cornified envelope. British Journal of 
Dermatology 2005; 152: 146-149.
[6] Suárez-Fariñas M, Ungar B, Correa 
da Rosa J, et al. RNA sequencing atopic 
dermatitis transcriptome profiling 
provides insights into novel disease 
mechanisms with potential therapeutic 
implications. Journal of Allergy 
and Clinical Immunology 2015; 135: 
1218-1227.
[7] Esaki H, Ewald DA, Ungar B, et al. 
Identification of novel immune and 
barrier genes in atopic dermatitis by 
means of laser capture microdissection. 
Journal of Allergy and Clinical 
Immunology 2015; 135: 153-163.
[8] Cole C, Kroboth K, Schurch NJ,  
et al. Filaggrin-stratified transcriptomic 
analysis of pediatric skin identifies 
mechanistic pathways in patients with 
atopic dermatitis. Journal of Allergy and 
Clinical Immunology 2014; 134: 82-91.
[9] Hamidi T, Singh AK, Chen T. 
Genetic alterations of DNA methylation 
machinery in human diseases. 
Epigenomics 2015; 7: 247-265.
[10] Zhang J, Yang C, Wu C, et al. DNA 
Methyltransferases in Cancer: Biology, 
Paradox, Aberrations, and Targeted 
Therapy. Cancers 2020; 12: 2123.
[11] Nakamura T, Sekigawa I,  
Ogasawara H, et al. Expression of 
DNMT-1 in patients with atopic 
dermatitis. Arch Dermatol Res 2006; 298: 
253-256.
[12] Ogawa H, Yoshiike T. A speculative 
view of atopic dermatitis: barrier 
dysfunction in pathogenesis. Journal of 
Dermatological Science 1993; 5: 197-204.
[13] Sekigawa I, Yoshiike T, Iida N, et 
al. Allergic diseases in systemic lupus 
erythematosus: prevalence and 
immunological considerations. Clin Exp 
Rheumatol 2003; 21: 117-121.
[14] Hamid Q, Boguniewicz M, 
Leung DY. Differential in situ cytokine 
gene expression in acute versus chronic 
atopic dermatitis. J Clin Invest 1994; 94: 
870-876.
[15] Reijsen FC, Wijburg OLC, 
Gebhardt M, et al. Different growth 
factor requirements for human Th2 
cells may reflect in vivo induced anergy. 
Clinical & Experimental Immunology 
2008; 98: 151-157.
[16] Kuwabara N, Kondo N, 
Fukutomi O, et al. METHYLATION 
PATTERNS OF I ? REGION IN B CELLS 
STIMULATED WITH INTERLEUKIN 
4 AND EPSTEIN-BARR VIRUS IN 
PATIENTS WITH A HIGH LEVEL OF 
Atopic Dermatitis - Essential Issues
12
SERUM IgE. Eur J Immunogenet 1995; 
22: 265-275.
[17] Lorenzo PR 1st null, Kuwabara N, 
Kondo N, et al. IgE production by 
B-cells stimulated with interleukin-4 
and Epstein-Barr virus in patients with 
elevated serum IgE levels. J Investig 
Allergol Clin Immunol 1995; 5: 78-81.
[18] Liang Y, Wang P, Zhao M, et 
al. Demethylation of the FCER1G 
promoter leads to FcεRI overexpression 
on monocytes of patients with atopic 
dermatitis: DNA methylation regulates 
AD monocyte FcεRI expression. Allergy 
2012; 67: 424-430.
[19] Novak N. New insights into the 
mechanism and management of allergic 
diseases: atopic dermatitis. Allergy 2009; 
64: 265-275.
[20] Novak N, Allam P, Geiger E, et al. 
Characterization of monocyte subtypes 
in the allergic form of atopic eczema/
dermatitis syndrome. Allergy 2002; 57: 
931-935.
[21] Ying S, O’Connor B, Ratoff J, et 
al. Thymic Stromal Lymphopoietin 
Expression Is Increased in Asthmatic 
Airways and Correlates with Expression 
of Th2-Attracting Chemokines and 
Disease Severity. J Immunol 2005; 174: 
8183-8190.
[22] Yoo J, Omori M, Gyarmati D, et al. 
Spontaneous atopic dermatitis in mice 
expressing an inducible thymic stromal 
lymphopoietin transgene specifically 
in the skin. Journal of Experimental 
Medicine 2005; 202: 541-549.
[23] Millington GW. Epigenetics 
and dermatological disease. 
Pharmacogenomics 2008; 9: 1835-1850.
[24] Soumelis V, Reche PA, Kanzler H, 
et al. Human epithelial cells trigger 
dendritic cell–mediated allergic 
inflammation by producing TSLP. Nat 
Immunol 2002; 3: 673-680.
[25] Crossno JT, Majka SM, Grazia T,  
et al. Rosiglitazone promotes 
development of a novel adipocyte 
population from bone marrow–derived 
circulating progenitor cells. J Clin Invest 
2006; 116: 3220-3228.
[26] Luo Y, Zhou B, Zhao M, et al. 
Promoter demethylation contributes to 
TSLP overexpression in skin lesions of 
patients with atopic dermatitis. Clin Exp 
Dermatol 2014; 39: 48-53.
[27] Wang I-J, Chen S-L, Lu T-P, et 
al. Prenatal smoke exposure, DNA 
methylation, and childhood atopic 
dermatitis. Clin Exp Allergy 2013; 43: 
535-543.
[28] Cho H-J, Sheen YH, Kang M-J, 
et al. Prenatal 25-hydroxyvitamin D 
deficiency affects development of atopic 
dermatitis via DNA methylation. Journal 
of Allergy and Clinical Immunology 2019; 
143: 1215-1218.
[29] Terman JR, Mao T, Pasterkamp RJ, 
et al. MICALs, a Family of Conserved 
Flavoprotein Oxidoreductases, Function 
in Plexin-Mediated Axonal Repulsion. 
Cell 2002; 109: 887-900.
[30] Ba X, Bacsi A, Luo J, et al. 
8-Oxoguanine DNA Glycosylase-1 
Augments Proinflammatory 
Gene Expression by Facilitating 
the Recruitment of Site-Specific 
Transcription Factors. JI 2014; 192: 
2384-2394.
[31] Noh Y-H, Lee J, Seo SJ, et al. 
Promoter DNA methylation contributes 
to human β -defensin-1 deficiency in 
atopic dermatitis. Animal Cells and 
Systems 2018; 22: 172-177.
[32] The ENCODE Project Consortium. 
Identification and analysis of functional 
elements in 1% of the human genome by 
13
Epigenetic Studies of Atopic Dermatitis
DOI: http://dx.doi.org/10.5772/intechopen.94092
the ENCODE pilot project. Nature 2007; 
447: 799-816.
[33] Han J, Park S-G, Bae J-B, et al. The 
characteristics of genome-wide DNA 
methylation in naïve CD4+ T cells 
of patients with psoriasis or atopic 
dermatitis. Biochemical and Biophysical 
Research Communications 2012; 422: 
157-163.
[34] Libert C, Dejager L, Pinheiro I. The 
X chromosome in immune functions: 
when a chromosome makes the 
difference. Nat Rev Immunol 2010; 10: 
594-604.
[35] Kaslow DC, Migeon BR. DNA 
methylation stabilizes X chromosome 
inactivation in eutherians but not in 
marsupials: evidence for multistep 
maintenance of mammalian X dosage 
compensation. Proceedings of the 
National Academy of Sciences 1987; 84: 
6210-6214.
[36] Rodríguez E, Baurecht H, Wahn AF, 
et al. An Integrated Epigenetic and 
Transcriptomic Analysis Reveals 
Distinct Tissue-Specific Patterns 
of DNA Methylation Associated 
with Atopic Dermatitis. Journal of 
Investigative Dermatology 2014; 134: 
1873-1883.
[37] Olisova OYu, Kochergin NG,  
Kayumova LN, et al. Skin DNA 
methylation profile in atopic dermatitis 
patients: A case–control study. Exp 
Dermatol 2020; 29: 184-189.
[38] Boorgula MP, Taub MA, Rafaels N, 
et al. Replicated methylation changes 
associated with eczema herpeticum and 
allergic response. Clin Epigenet 2019; 11: 
122.
[39] Liang Y, Chang C, Lu Q. The 
Genetics and Epigenetics of Atopic 
Dermatitis—Filaggrin and Other 
Polymorphisms. Clinic Rev Allerg 
Immunol 2016; 51: 315-328.
[40] Fontenot JD, Rasmussen JP, 
Williams LM, et al. Regulatory T Cell 
Lineage Specification by the Forkhead 
Transcription Factor Foxp3. Immunity 
2005; 22: 329-341.
[41] Polansky JK, Kretschmer K, Freyer J, 
et al. DNA methylation controls Foxp3 
gene expression. Eur J Immunol 2008; 
38: 1654-1663.
[42] Hinz D, Bauer M, Röder S, et al. 
Cord blood Tregs with stable FOXP3 
expression are influenced by prenatal 
environment and associated with atopic 
dermatitis at the age of one year. Allergy 
2012; 67: 380-389.
[43] White GP, Watt PM, Holt BJ, et al. 
Differential Patterns of Methylation 
of the IFN-γ Promoter at CpG and 
Non-CpG Sites Underlie Differences in 
IFN-γ Gene Expression Between Human 
Neonatal and Adult CD45RO − T Cells. J 
Immunol 2002; 168: 2820-2827.
[44] Kaminuma O, Kitamura F, 
Miyatake S, et al. T-box 21 transcription 
factor is responsible for distorted TH2 
differentiation in human peripheral 
CD4+ T cells. Journal of Allergy and 
Clinical Immunology 2009; 123:  
813-823.e3.
[45] Brand S, Teich R, Dicke T, et 
al. Epigenetic regulation in murine 
offspring as a novel mechanism for 
transmaternal asthma protection 
induced by microbes. Journal of Allergy 
and Clinical Immunology 2011; 128: 
618-625.e7.
[46] Makeyev EV, Maniatis T. Multilevel 
Regulation of Gene Expression 
by MicroRNAs. Science 2008; 319: 
1789-1790.
[47] Sonkoly E, Janson P, Majuri 
M-L, et al. MiR-155 is overexpressed 
in patients with atopic dermatitis 
and modulates T-cell proliferative 
responses by targeting cytotoxic 
Atopic Dermatitis - Essential Issues
14
T lymphocyte–associated antigen 
4. Journal of Allergy and Clinical 
Immunology 2010; 126: 581-589.e20.
[48] Herberth G, Bauer M, Gasch M,  
et al. Maternal and cord blood miR-223 
expression associates with prenatal 
tobacco smoke exposure and low 
regulatory T-cell numbers. Journal of 
Allergy and Clinical Immunology 2014; 
133: 543-550.e4.
